Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
68people with obesity, in this paper
The trial randomly assignedassigned by chance
liraglutide 1.2 mg/d
baseline (pre-treatment)
Reported lower liver fat content, no range given−31.0
randomisedthe abstract, start to end
… a marked relative reduction in LFC of 31% (P < 0.0001).
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Liver fat content (LFC)liraglutide 1.2 mg/d vs baseline (pre-treatment)
RR −31.0
GLP-1 receptor agonistsLiver & MASLD
1 / 4